直肠家族性腺瘤性息肉与癌组织中COX-2蛋白表达及意义

经病理证实合并门脉癌栓的肝癌患者50例。其中28例行肝癌切除，术中门脉取栓及肝切除无水酒精注射，术后肝动脉灌注栓塞化化主门脉化疗；另22例行肝癌切除，门脉取栓，术中未用无水酒精，术后无化疗，结果示观察组与对照组相比，术后并发症分别为7.1%和9.0%，术后0.5,1,3年生存分别为80.8%,73.1%,26.9%和71.4%,33.3%,0%。肝切除联合导管栓塞化疗及无水酒精注射是提高合并门脉癌栓的肝癌远期疗效的有效措施。

Hepatectomy combined with chemoembolization and ethanol injection for the treatment of liver cancer with portal vein tumor thrombi:a report of 28 cases.

All the 50 cases of liver cancer with PVTT have affirmed by the pathology The 28 cases of them,took the combined therapy The other 22 cases as the group of comparison,just took the hepatectomy combined with removal of tumor thrombi Comparing the two groups,the ndence rate of postoperative complication was 7 1% and 9 0% separately The survival rate at 0 5,1,3 year was 80 8%,37 1%,26 9% and 71 4%,33 3%,0% separately The combined therapy is effective measures to improved the late result of the liver cancer with PVTT